196 related articles for article (PubMed ID: 32671384)
1. Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia.
Omori W; Hattori K; Kajitani N; Tsuchioka MO; Boku S; Kunugi H; Okamoto Y; Takebayashi M
Int J Neuropsychopharmacol; 2020 Jul; 23(11):713-20. PubMed ID: 32671384
[TBL] [Abstract][Full Text] [Related]
2. Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
Omori W; Kano K; Hattori K; Kajitani N; Okada-Tsuchioka M; Boku S; Kunugi H; Aoki J; Takebayashi M
Int J Neuropsychopharmacol; 2021 Dec; 24(12):948-955. PubMed ID: 34214158
[TBL] [Abstract][Full Text] [Related]
3. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
Yoon HS; Hattori K; Sasayama D; Kunugi H
J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study.
Hidese S; Hattori K; Sasayama D; Tsumagari T; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Yoshida S; Ota M; Kunugi H
Transl Psychiatry; 2020 May; 10(1):161. PubMed ID: 32439851
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood BDNF-TrkB signaling in first-episode, drug-free patients with major depressive disorder and schizophrenia.
Chen L; Li XS; Zheng GE; Xie GJ; Cheng Y
Neurosci Lett; 2020 Jan; 714():134618. PubMed ID: 31711978
[TBL] [Abstract][Full Text] [Related]
6. Search for cerebrospinal fluid biomarkers in patients with major psychiatric disorders: Multiplex immunoassay findings and proximity extension assay prospects.
Hidese S
Neuropsychopharmacol Rep; 2024 Jun; 44(2):314-320. PubMed ID: 38686540
[TBL] [Abstract][Full Text] [Related]
7. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder.
Tkachev A; Stekolshchikova E; Vanyushkina A; Zhang H; Morozova A; Zozulya S; Kurochkin I; Anikanov N; Egorova A; Yushina E; Vogl T; Senner F; Schaupp SK; Reich-Erkelenz D; Papiol S; Kohshour MO; Klöhn-Saghatolislam F; Kalman JL; Heilbronner U; Heilbronner M; Gade K; Comes AL; Budde M; Anderson-Schmidt H; Adorjan K; Wiltfang J; Reininghaus EZ; Juckel G; Dannlowski U; Fallgatter A; Spitzer C; Schmauß M; von Hagen M; Zorkina Y; Reznik A; Barkhatova A; Lisov R; Mokrov N; Panov M; Zubkov D; Petrova D; Zhou C; Liu Y; Pu J; Falkai P; Kostyuk G; Klyushnik T; Schulze TG; Xie P; Schulte EC; Khaitovich P
JAMA Psychiatry; 2023 Mar; 80(3):250-259. PubMed ID: 36696101
[TBL] [Abstract][Full Text] [Related]
8. Association between the loudness dependence of auditory evoked potentials and age in patients with schizophrenia and depression.
Jang KI; Kim S; Lee C; Chae JH
J Int Med Res; 2022 Jul; 50(7):3000605221109789. PubMed ID: 35808808
[TBL] [Abstract][Full Text] [Related]
9. People with current major depression resemble healthy controls on flash Electroretinogram indices associated with impairment in people with stabilized schizophrenia.
Demmin DL; Netser R; Roché MW; Thompson JL; Silverstein SM
Schizophr Res; 2020 May; 219():69-76. PubMed ID: 31375317
[TBL] [Abstract][Full Text] [Related]
10. Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression.
Kochunov P; Glahn DC; Rowland LM; Olvera RL; Winkler A; Yang YH; Sampath H; Carpenter WT; Duggirala R; Curran J; Blangero J; Hong LE
Biol Psychiatry; 2013 Mar; 73(5):482-91. PubMed ID: 23200529
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder.
Wang F; Guo L; Zhang T; Cui Z; Wang J; Zhang C; Xue F; Zhou C; Li B; Tan Q; Peng Z
Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363466
[No Abstract] [Full Text] [Related]
12. Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.
Castellazzi M; Ligi D; Contaldi E; Quartana D; Fonderico M; Borgatti L; Bellini T; Trentini A; Granieri E; Fainardi E; Mannello F; Pugliatti M
Front Neurol; 2018; 9():1080. PubMed ID: 30619040
[No Abstract] [Full Text] [Related]
13. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
14. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Negative Symptoms and Neurocognition on Functioning in MDD and Schizophrenia.
Quek YF; Yang Z; Dauwels J; Lee J
Front Psychiatry; 2021; 12():648108. PubMed ID: 34381384
[No Abstract] [Full Text] [Related]
16. [Anatomic Abnormalities of Hippocampal Subfields in First-Episode Drug-Naïve Schizophrenia and Major Depressive Disorder: A Structural MRI Comparative Study].
Sun Y; Tang BQ; Zhu F; Zhang WJ; Zhao YJ; Gong QY; Hu N; Lyu S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):275-280. PubMed ID: 36949685
[TBL] [Abstract][Full Text] [Related]
17. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
18. Using Clinical Characteristics to Identify Which Patients With Major Depressive Disorder Have a Higher Genetic Load for Three Psychiatric Disorders.
Verduijn J; Milaneschi Y; Peyrot WJ; Hottenga JJ; Abdellaoui A; de Geus EJC; Smit JH; Breen G; Lewis CM; Boomsma DI; Beekman ATF; Penninx BWJH
Biol Psychiatry; 2017 Feb; 81(4):316-324. PubMed ID: 27576130
[TBL] [Abstract][Full Text] [Related]
19. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
20. Range adaptive value representations in schizophrenia and major depression.
Wang LL; Lui SSY; So JWL; Hu HX; Chu MY; Cheng KM; Li SB; Le BL; Lv QY; Yi ZH; Chan RCK
Asian J Psychiatr; 2024 Feb; 92():103880. PubMed ID: 38157714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
